Veryan Medical, Ltd.

Breakthrough in treatment for kidney dialysis patients developed

Published in Physician Law Weekly, September 1st, 2004

A ground-breaking medical approach that could substantially improve the quality of life for more than a million kidney dialysis patients, and bring savings to health services, is one step closer to becoming a reality, thanks to NESTA (the National Endowment of Science, Technology and the Arts), an organization that backs U.K. innovation.

NESTA has invested 95,000 pounds in a university spinout, Veryan Medical, Ltd., based at London's Imperial College, to further develop its ground-breaking approach. The company has been financed to date by NPI Ventures, Ltd., and Imperial College Innovations.

Veryan is dedicated to developing a number of novel...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly

Source: Physician Law Weekly (2004-09-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry